Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.

Source:http://linkedlifedata.com/resource/pubmed/id/11691814

Cancer Res. 2001 Nov 1 61 21 7925-33

Download in:

View as

General Info

PMID
11691814